5 trends shaping the future of ecommerce
The genomics revolution: why investors are paying attention
At the center of the genomics revolution is big data and DNA.
The implications are vast. Thanks to recent advances, faster cancer detection is within reach, potentially saving thousands of lives each year. A first research study shows that this technology could save 66,000 live annually in the United States only.
In addition, genomic innovation goes beyond the simple detection of cancer. Today, he covers a variety of innovations, from gene editing to anticancer drugs.
In this chart from MSCI, we take a look at four reasons the genomics industry is positioned for growth through powerful applications in medicine.
What is the genomic revolution?
For starters, the genomic revolution focuses on the study of the human genome, a complete set of human (or organism) DNA.
A human is made up of 23 pairs of chromosomes and 24,000 genes. Taken together, the human genetic code is equivalent to three billion letters of DNA. Since most diseases are related to our genetic condition, genomics involves the editing, mapping, and function of a genome.
Through genomic innovation, large-scale applications of diagnostics and decision support tools are made possible for a wide range of diseases.
4 ways the genomics revolution is changing medicine
Over the past century, the field of genomics has advanced faster than any other discipline in the life sciences.
The landmark achievement is the Human Genome Project completed in 2001. Since then, scientists have analyzed the genes of thousands of people to identify the cause of heart disease, cancer and other fatal ailments.
Here are four areas where genomic innovation is making a big difference in the medical field.
1. Modification of genes
Editing genes allows scientists to change someone’s DNA, such as eye color. Generally speaking, gene editing involves cutting DNA at a certain point and adding, removing, or replacing that DNA.
For example, gene editing makes it possible to use live drugs. As the name suggests, live medicines are made from living organisms that harness a body’s immune system or other bodily processes, and use them to fight disease.
According to ARK Invest analysis, live drugs have potential $ 200 billion addressable market.
2. Cancer detection
Multi-cancer screening, supported by genomic sequencing and liquid biopsies, is expected to prevent more cancer deaths than any other medical innovation.
With just one blood test, several types of cancer can be detected early thanks to advances in synthetic biology. Scientists use genomic sequencing (also called DNA sequencing) to identify an organism’s genetic makeup, or a change in a gene that can lead to cancer.
Importantly, screening costs are dropping rapidly, from $ 30,000 in 2015 to $ 1,500 in 2021. The combination of these factors is boosting potential. 150 billion dollars Marlet. It could be revolutionary for healthcare by moving from a treatment-based model to a more preventative model in the future.
3. DNA sequencing
A modern form of DNA sequencing is long read DNA sequencing. With long-read DNA sequencing, scientists can identify genetic sequences faster and at lower cost.
For these reasons, long-read DNA sequencing is expected to reach a market of $ 5 billion, with growth 82% annual rate.
4. Agricultural biology
Finally, the genomic revolution is making progress in agricultural biology. Here, the research examines how to reduce the cost of crop production, improve plant breeding, and improve quality.
Study shows that advances in genomics in agriculture have led to sixfold increased income for some farmers.
Investing in the genomics revolution
A number of genomics-focused companies have shown promising returns.
This can be illustrated by the MSCI ACWI Genomic Innovation Index, which outperformed the benchmark by nearly 50% since 2013. The index, which was developed with ARK Invest, includes around 250 companies working in the field of genomic innovation. In 2020 alone, the index returned more than 43%.
From diagnosis to prevention, the genomics revolution is innovating in the field of scalable solutions for global health. Investment opportunities are expected to follow.